Skip to content

HLA and perforated peptic ulcer

Prospective observational study to analyze the association between the pathogenesis of perforated peptic ulcers and HLA. - Prospective observational study to analyze the association between the pathogenesis of perforated peptic ulcers and HLA.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000053659
Enrollment
500
Registered
2024-02-26
Start date
1977-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peptic ulcer

Interventions

None listed

Sponsors

Study Group for Gastroenterological Disease
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Perforated peptic ulcers and non-perforated peptic ulcers whose HLA was measured, including cases in which prior treatment and diagnosis (endoscopy, etc.) were confirmed.

Exclusion criteria

Exclusion criteria: NP

Design outcomes

Primary

MeasureTime frame
Clinical risk factors between peptic ulcer patients who perforated and not and HLA.

Secondary

MeasureTime frame
Ulcer recurrence, subsequent gastric cancer and multiple primary malignancy.

Countries

Japan

Contacts

Public ContactKyoji Ogoshi

Tokai University Department of Surgery

ogoshik@gmail.com0463-96-6163

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026